Optiver Holding B.V. Greenwich Life Sciences, Inc. Transaction History
Optiver Holding B.V.
- $6 Billion
- Q3 2025
A detailed history of Optiver Holding B.V. transactions in Greenwich Life Sciences, Inc. stock. As of the latest transaction made, Optiver Holding B.V. holds 96 shares of GLSI stock, worth $804. This represents 0.0% of its overall portfolio holdings.
Number of Shares
96Holding current value
$804% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding GLSI
# of Institutions
48Shares Held
1.14MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY309KShares$2.59 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA282KShares$2.36 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA142KShares$1.19 Million0.0% of portfolio
-
State Street Corp Boston, MA81.9KShares$686,7070.0% of portfolio
-
Northern Trust Corp Chicago, IL75.9KShares$636,0830.0% of portfolio
About Greenwich LifeSciences, Inc.
- Ticker GLSI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 12,848,200
- Market Cap $108M
- Description
- Greenwich LifeSciences, Inc., a clinical stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for breast cancer and other HER2/neu-expressing cancers. Its lead product candidate is the GP2, an immunotherapy, which has completed Phase IIb clinical trial to prevent breast cancer recurrences in patients who ha...